Mutations of SETD2 were observed and extensively studied in certain malignancies, such as clear-cell renal-cell carcinoma (ccRCC), colorectal cancer, lungs, gastric, glioma, and colorectal cancer [8,9,10,11]. The gene discussed is SETD2; the disease is clear cell renal carcinoma.